Millie Das

Cancer Prevention Institute of California

Also affiliated with VA Palo Alto Health Care System, Stanford Medicine, Stanford University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition”.

KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0282

N/A

0.775DataRank · unranked

174 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +26 more

Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis

Nature Cell Biology(2023)10.1038/s41556-023-01241-6

N/A

0.681DataRank · unranked

93 citations

Siqi Cao, Wojciech Michno, Chioma J. Madubata, Griffin G. Hartmann, Alyssa Puno +17 more

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Journal of Clinical Oncology(2023)10.1200/jco.23.01435

N/A

0.593DataRank · unranked

51 citations

Nofisat Ismaila, Jessica Bian, Raetasha Dabney, Millie Das, Peter Ellis +12 more

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101381

N/A

0.529DataRank · unranked

33 citations

Timothy Chai, Fernando Jose Garcia-Marques, Qingqing Yin, En‐Chi Hsu, Michelle Shen +25 more

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100174

N/A

0.406DataRank · unranked

14 citations

Nadine S. Jahchan, Millie Das, Michael Zach Koontz, Pamela L. Kunz, Heather A. Wakelee +4 more

[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy

Journal of Nuclear Medicine(2024)10.2967/jnumed.124.268253

N/A

0.341DataRank · unranked

6 citations

Millie Das, Minal Vasanawala, Deepti Behl, Martin G. Pomper, Patrick M. Forde +12 more

Improving supportive care for patients with Thoracic Malignancies – A randomized controlled trial

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.100929

N/A

0.232DataRank · unranked

3 citations

Lakedia Banks, Millie Das, Manali I. Patel

KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9012

N/A

0.104DataRank · unranked

1 citations

Young-Jun Jeon, Monica Nesselbush, Everett J. Moding, Barzin Y. Nabet, Diego Almanza +15 more

A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9046

N/A

0.104DataRank · unranked

1 citations

Mohammad Shahrokh Esfahani, Barzin Y. Nabet, Yufei Liu, Jacob J. Chabon, Jianzhong He +15 more

Neuronal mimicry generates an ecosystem critical for brain metastatic growth of SCLC

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.10.455426

N/A

0DataRank · unranked

4 citations

Siqi Cao, Wojciech Michno, Chioma J. Madubata, Alyssa Puno, Alexandros P. Drainas +9 more

Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes

JTO Clinical and Research Reports(2025)10.1016/j.jtocrr.2025.100914

N/A

0DataRank · unranked

0 citations

Caressa Hui, Joel W. Neal, Seema Nagpal, Mohana Roy, Millie Das +6 more

Mitochondrial Imaging Detects Early Cardiac Responses to Cancer Immunotherapy

medRxiv(2025)10.1101/2025.10.13.25337690

N/A

0DataRank · unranked

0 citations

Uttam Shrestha, Millie Das, Minal Vasanawala, Deepti Behl, Diwakar Davar +17 more

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.888

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Joel W. Neal, Kavitha Ramchandran, Millie Das, Seema Nagpal +5 more

Improving supportive care for patients with thoracic cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1520

N/A

0DataRank · unranked

0 citations

Kris Kapphahn, Millie Das, Debra Wujcik, Carrie Tompkins Stricker, Lucinda Shanbhag +4 more

Advances in the Treatment of Stage III Non–Small Cell Lung Cancer

Clinics in Chest Medicine(2020)10.1016/j.ccm.2020.02.008

N/A

0DataRank · unranked

22 citations

Millie Das, Nathaniel J. Myall

Cost–effectiveness of Adjuvant Atezolizumab for Patients with Stage II–IIIA PD-L1+ Non-Small-Cell Lung Cancer

Immunotherapy(2023)10.2217/imt-2022-0311

N/A

0DataRank · unranked

11 citations

Sarika Ogale, Nick Jovanoski, Ann Johnson, Caroline T. Nguyen, Jan Bhagwakar +2 more